Activation of the nuclear receptor FXR induces fibrinogen expression: A new role for bile acid signaling

Journal of Lipid Research

Volumn 46, Issue 3, 2005, Pages 458-468

  Anisfeld, Andrew M ^a   Kast Woelbern, Heidi R ^a   Lee, Hans ^a   Zhang, Yanqiao ^a   Lee, Florence Y ^a   Edwards, Peter A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 (2,6 dichlorophenyl) 4 (3 carboxy 2 chloro stilben 4 yl) oxymethyl 5 isopropyl isoxazole; Chenodeoxycholic acid; Farnesoid X receptor; Nuclear hormone receptor

Indexed keywords

3 (2,6 DICHLOROPHENYL) 4 (3' CARBOXY 2 CHLOROSTILBEN 4 YL)OXYMETHYL 5 ISOPROPYL ISOXAZOLE; BILE ACID; CYCLOHEXIMIDE; DACTINOMYCIN; FARNESOID X RECEPTOR; FIBRINOGEN; ISOPROTEIN; ISOXAZOLE DERIVATIVE; UNCLASSIFIED DRUG; CELL RECEPTOR; DNA BINDING PROTEIN; FARNESOID X-ACTIVATED RECEPTOR; LIGAND; MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; FIBRINOLYSIS; GENE IDENTIFICATION; GENE INDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

BILE ACIDS AND SALTS; CELL LINE, TUMOR; CYCLOHEXIMIDE; DACTINOMYCIN; DNA-BINDING PROTEINS; FIBRINOGEN; GENE EXPRESSION REGULATION; HUMANS; ISOXAZOLES; LIGANDS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 24144461348     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M400292-JLR200     Document Type: Article

References (47)

1. Koenig, W. 2003. Fibrin(ogen) in cardiovascular disease: an update. Thromb. Haemost. 89: 601-609.
2. McKee, P. A., L. A. Rogers, E. Marler, and R. L. Hill. 1966. The subunit polypeptides of human fibrinogen. Arch. Biochem. Biophys. 116: 271-279.
3. Chien, K. R. 1999. Molecular Basis of Cardiovascular Disease. W. B. Saunders Co., Philadelphia.
4. Fuller, G. M., and Z. Zhang. 2001. Transcriptional control mechanism of fibrinogen gene expression. Ann. NY Acad. Sci. 936: 469-479.
5. Kant, J. A., A. J. Fornace, Jr., D. Saxe, M. I. Simon, O. W. McBride, and G. R. Crabtree. 1985. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc. Natl. Acad. Sci. USA. 82: 2344-2348.
6. Henry, I., G. Uzan, D. Weil, H. Nicolas, J. C. Kaplan, C. Marguerie, A. Kahn, and C. Junien. 1984. The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am. J. Hum. Genet. 36: 760-768.
7. Dalmon, J., M. Laurent, and G. Courtois. 1993. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6- responsive element. Mol. Cell. Biol. 13: 1183-1193.
8. Courtois, G., J. G. Morgan, L. A. Campbell, G. Fourel, and G. R. Crabtree. 1987. Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science. 238: 688-692.
9. Otto, J. M., H. E. Grenett, and G. M. Fuller. 1987. The coordinated regulation of fibrinogen gene transcription by hepatocyte-stimulating factor and dexamethasone. J. Cell Biol. 105: 1067-1072.
10. Mizuguchi, J., C. H. Hu, Z. Cao, K. R. Loeb, D. W. Chung, and E. W. Davie. 1995. Characterization of the 5′-flanking region of the gene for the gamma chain of human fibrinogen. J. Biol. Chem. 270: 28350-28356.
11. Hu, C. H., J. E. Harris, E. W. Davie, and D. W. Chung. 1995. Characterization of the 5′-flanking region of the gene for the alpha chain of human fibrinogen. J. Biol. Chem. 270: 28342-28349.
12. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell. 83: 841-850.
13. Nolte, R. T., G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, and M. V. Milburn. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator- activated receptor-gamma. Nature. 395: 137-143.
14. Westin, S., R. Kurokawa, R. T. Nolte, G. B. Wisely, E. M. McInerney, D. W. Rose, M. V. Milburn, M. G. Rosenfeld, and C. K. Glass. 1998. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature. 395: 199-202.
15. Zhang, Y., H. R. Kast-Woelbern, and P. A. Edwards. 2003. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J. Biol. Chem. 278: 104-110.
16. Huber, R. M., K. Murphy, B. Miao, J. R. Link, M. R. Cunningham, M. J. Rupar, P. L. Gunyuzlu, T. F. Haws, A. Kassam, F. Powell, G. F. Hollis, P. R. Young, R. Mukherjee, and T. C. Burn. 2002. Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene. 290: 35-43.
17. Anisfeld, A. M., H. R. Kast-Woelbern, M. E. Meyer, S. A. Jones, Y. Zhang, K. J. Williams, T. Willson, and P. A. Edwards. 2003. Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor. J. Biol. Chem. 278: 20420-20428.
18. Makishima, M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan. 1999. Identification of a nuclear receptor for bile acids. Science. 284: 1362-1365.
19. Parks, D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, and J. M. Lehmann. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284: 1365-1368.
20. Wang, H., J. Chen, K. Hollister, L. C. Sowers, and B. M. Forman. 1999. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3: 543-553.
21. Sinal, C. J., M. Tohkin, M. Miyata, J. M. Ward, G. Lambert, and F. J. Gonzalez. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 102: 731-744.
22. Edwards, P. A., H. R. Kast, and A. M. Anisfeld. 2002. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid Res. 43: 2-12.
23. Ananthanarayanan, M., N. Balasubramanian, M. Makishima, D. J. Mangelsdorf, and F. J. Suchy. 2001. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 276: 28857-28865.
24. Kast, H. R., B. Goodwin, P. T. Tarr, S. A. Jones, A. M. Anisfeld, C. M. Stoltz, P. Tontonoz, S. Kliewer, T. M. Willson, and P. A. Edwards. 2002. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277: 2908-2915.
25. Huang, L., A. Zhao, J. L. Lew, T. Zhang, Y. Hrywna, J. R. Thompson, N. de Pedro, I. Royo, R. A. Blevins, F. Pelaez, S. D. Wright, and J. Cui. 2003. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J. Biol. Chem. 278: 51085-51090.
26. Liu, Y., J. Binz, M. J. Numerick, S. Dennis, G. Luo, B. Desai, K. I. MacKenzie, T. A. Mansfield, S. A. Kliewer, B. Goodwin, and S. A. Jones. 2003. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J. Clin. Invest. 112: 1678-1687.
27. Holt, J. A., G. Luo, A. N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, Y. da Wang, T. A. Mansfield, S. A. Kliewer, B. Goodwin and S. A. Jones. 2003. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17: 1581-1591.
28. Goodwin, B., S. A. Jones, R. R. Price, M. A. Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, P. R. Maloney, T. M. Willson, and S. A. Kliewer. 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell. 6: 517-526.
29. Kerr, T. A., S. Saeki, M. Schneider, K. Schaefer, S. Berdy, T. Redder, B. Shan, D. W. Russell, and M. Schwarz. 2002. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev. Cell. 2: 713-720.
30. Wang, L., Y. K. Lee, D. Bundman, Y. Han, S. Thevananther, C. S. Kim, S. S. Chua, P. Wei, R. A. Heyman, M. Karin, and D. D. Moore. 2002. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell. 2: 721-731.
31. Lu, T. T., M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx, and D. J. Mangelsdorf. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell. 6: 507-515.
32. Watanabe, M., S. M. Houten, L. Wang, A. Moschetta, D. J. Mangelsdorf, R. A. Heyman, D. D. Moore, and J. Auwerx. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113: 1408-1418.
33. Zhang, Y., L. W. Castellani, C. J. Sinal, F. J. Gonzalez, and P. A. Edwards. 2004. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 18: 157-169.
34. Claudel, T., Y. Inoue, O. Barbier, D. Duran-Sandoval, V. Kosykh, J. Fruchart, J. C. Fruchart, F. J. Gonzalez, and B. Staels. 2003. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology. 125: 544-555.
35. Sirvent, A., T. Claudel, G. Martin, J. Brozek, V. Kosykh, R. Darteil, D. W. Hum, J. C. Fruchart, and B. Staels. 2004. The farnesoid X receptor induces very low density lipoprotein receptor gene expression. FEBS Lett. 566: 173-177.
36. Bell, G. D., B. Lewis, A. Petrie, and R. H. Dowling. 1973. Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. BMJ. 3: 520-523.
37. Wagner, M., P. Fickert, G. Zollner, A. Fuchsbichler, D. Silbert, O. Tsybrovskyy, K. Zatloukal, G. L. Guo, J. D. Schuetz, F. J. Gonzalez, H. U. Marschall, H. Denk, and M. Trauner. 2003. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology. 125: 825-838.
38. Yamagata, K., H. Daitoku, Y. Shimamoto, H. Matsuzaki, K. Hirota, J. Ishida, and A. Fukamizu. 2004. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J. Biol. Chem. 279: 23158-23165.
39. Zhao, A., J. L. Lew, L. Huang, J. Yu, T. Zhang, Y. Hrywna, J. R. Thompson, N. de Pedro, R. A. Blevins, F. Pelaez, S. D. Wright, and J. Cui. 2003. Human kininogen gene is transactivated by the farnesoid X receptor. J. Biol. Chem. 278: 28765-28770.
40. Downes, M., M. A. Verdecia, A. J. Roecker, R. Hughes, J. B. Hogenesch, H. R. Kast-Woelbern, M. E. Bowman, J. L. Ferrer, A. M. Anisfeld, P. A. Edwards, J. M. Rosenfeld, J. G. Alvarez, J. P. Noel, K. C. Nicolaou, and R. M. Evans. 2003. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol. Cell. 11: 1079-1092.
41. Maloney, P. R., D. J. Parks, C. D. Haffner, A. M. Fivush, G. Chandra, K. D. Plunket, K. L. Creech, L. B. Moore, J. G. Wilson, M. C. Lewis, S. A. Jones, and T. M. Willson. 2000. Identification of a chemical tool for the orphan nuclear receptor FXR. J. Med. Chem. 43: 2971-2974.
42. Kast, H. R., C. M. Nguyen, C. J. Sinal, S. A. Jones, B. A. Laffitte, K. Reue, F. J. Gonzalez, T. M. Willson, and P. A. Edwards. 2001. Activated FXR induces apoC-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol. Endocrinol. 15: 1720-1728.
43. Yu, S., B. Sher, B. Kudryk, and C. M. Redman. 1984. Fibrinogen precursors. Order of assembly of fibrinogen chains. J. Biol. Chem. 259: 10574-10581.
44. Seol, W., H. S. Choi, and D. D. Moore. 1995. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9: 72-85.
45. Laffitte, B. A., H. R. Kast, C. M. Nguyen, A. M. Zavacki, D. D. Moore, and P. A. Edwards. 2000. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J. Biol. Chem. 275: 10638-10647.
46. Kardassis, D., E. Sacharidou, and V. I. Zannis. 1998. Transactivation of the human apolipoprotein CII promoter by orphan and ligand-dependent nuclear receptors. The regulatory element CIIC is a thyroid hormone response element. J. Biol. Chem. 273: 17810-17816.
47. Scarabin, P. Y., D. Arveiler, P. Amouyel, C. Dos Santos, A. Evans, G. Luc, J. Ferrieres, and I. Juhan-Vague. 2003. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME Study. Atherosclerosis. 166: 103-109.